According to
Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best health information service stocks to buy right now are:
1. Omnicell (NASDAQ:OMCL)
Omnicell (NASDAQ:OMCL) is the #1 top health information service stock out of 52 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year.
Learn more.
The Component Grade breakdown for Omnicell (NASDAQ:OMCL) is: Value: B, Growth: A, Momentum: C, Sentiment: A, Safety: B, Financials: C, and AI: C.
Omnicell (NASDAQ:OMCL) has a Due Diligence Score of 50, which is 19 points higher than the health information service industry average of 31.
OMCL passed 16 out of 33 due diligence checks and has strong fundamentals. Omnicell has seen its stock return 24.95% over the past year, overperforming other health information service stocks by 75 percentage points.
Omnicell has an average 1 year
price target of $58.50, an upside of 57.64% from Omnicell's current stock price of $37.11.
Omnicell stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Omnicell, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.
2. Nrc Health (NASDAQ:NRC)
Nrc Health (NASDAQ:NRC) is the #2 top health information service stock out of 52 with a Zen Rating of B. Stocks with a rating of B have had an average return of +17.17% per year.
Learn more.
The Component Grade breakdown for Nrc Health (NASDAQ:NRC) is: Value: C, Growth: C, Momentum: C, Sentiment: B, Safety: B, Financials: B, and AI: C.
Nrc Health (NASDAQ:NRC) has a Due Diligence Score of 25, which is -6 points lower than the health information service industry average of 31. Although this number is below the industry average, our proven quant model rates NRC as a "B".
NRC passed 10 out of 38 due diligence checks and has weak fundamentals. Nrc Health has seen its stock return 49.72% over the past year, overperforming other health information service stocks by 100 percentage points.
Nrc Health has an average 1 year
price target of $26.00, an upside of 37.49% from Nrc Health's current stock price of $18.91.
Nrc Health stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Nrc Health, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.
3. Optimizerx (NASDAQ:OPRX)
Optimizerx (NASDAQ:OPRX) is the #3 top health information service stock out of 52 with a Zen Rating of B. Stocks with a rating of B have had an average return of +17.17% per year.
Learn more.
The Component Grade breakdown for Optimizerx (NASDAQ:OPRX) is: Value: A, Growth: C, Momentum: F, Sentiment: B, Safety: C, Financials: B, and AI: C.
Optimizerx (NASDAQ:OPRX) has a Due Diligence Score of 47, which is 16 points higher than the health information service industry average of 31.
OPRX passed 15 out of 33 due diligence checks and has strong fundamentals. Optimizerx has seen its stock lose -50.4% over the past year.
Optimizerx has an average 1 year
price target of $12.00, an upside of 91.39% from Optimizerx's current stock price of $6.27.
Optimizerx stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Optimizerx, 80% have issued a Strong Buy rating, 0% have issued a Buy, 20% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.
